Novartis Series B Stock Financing

In April 2011, our lawyers represented Novartis Bioventures in the $13,945,340 Series B Stock Financing and second closing of a Series B Investment in Akebia Therapeutics, Inc. Akebia Therapeutics, Inc., based in Cincinnati, Ohio, is a biopharmaceutical company that engages in the discovery and development of small molecules for the treatment of anemia and vascular disorders. Akebia Therapeutics, Inc. was founded in 2007. Novartis Bioventures, is a venture fund based in Cambridge, Massachusetts.
Posted on April 21, 2011